Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

Peer-based Retention of people who Use Drugs in Rural Research (PROUD-R 2): A multisite, randomised, 12-month trial to compare efficacy of standard versus peer-based approaches to retain rural people who use drugs in research

  • April M. Young
  • , Kathryn E. Lancaster
  • , Sarann Bielavitz
  • , Miriam R. Elman
  • , Ryan R. Cook
  • , Gillian Leichtling
  • , Edward Freeman
  • , Angela T. Estadt
  • , Morgan Brown
  • , Rhonda Alexander
  • , Caiti Barrie
  • , Kandi Conn
  • , Rhody Elzaghal
  • , Lisa Maybrier
  • , Renee McDowell
  • , Cathy Neal
  • , Jodi Lapidus
  • , Elizabeth N. Waddell
  • , P. Todd Korthuis

Producción científica: Articlerevisión exhaustiva

8 Citas (Scopus)

Resumen

Introduction Rural communities bear a disproportionate share of the opioid and methamphetamine use disorder epidemics. Yet, rural people who use drugs (PWUD) are rarely included in trials testing new drug use prevention and treatment strategies. Numerous barriers impede rural PWUD trial engagement and advancing research methods to better retain rural PWUD in clinical trials is needed. This paper describes the Peer-based Retention Of people who Use Drugs in Rural Research (PROUD-R 2) study protocol to test the effectiveness of a peer-driven intervention to improve study retention among rural PWUD. Methods and analysis The PROUD-R 2 study is being implemented in 21 rural counties in three states (Kentucky, Ohio and Oregon). People who are 18 years or older, reside in the study area and either used opioids or injected any drug to get high in the past 30 days are eligible for study inclusion. Participants are allocated in a 1:1 ratio to two arms, stratified by site to assure balance at each geographical location. The trial compares the effectiveness of two retention strategies. Participants randomised to the control arm provide detailed contact information and receive standard retention outreach by study staff (ie, contacts for locator information updates, appointment reminders). Participants randomised to the intervention arm are asked to recruit a 'study buddy' in addition to receiving standard retention outreach. Study buddies are invited to participate in a video training and instructed to remind their intervention participant of follow-up appointments and encourage retention. Assessments are completed by intervention, control and study buddy participants at 6 and 12 months after enrolment. Ethics and dissemination The protocol was approved by a central Institutional Review Board (University of Utah). Results of the study will be disseminated in academic conferences and peer-reviewed journals, online and print media, and in meetings with community stakeholders.

Idioma originalEnglish
Número de artículoe064400
PublicaciónBMJ Open
Volumen12
N.º6
DOI
EstadoPublished - jun 15 2022

Nota bibliográfica

Publisher Copyright:
© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Financiación

PROUD-R2 is funded by the National Institutes of Health through NCATS U01TR002631 (MPIs: Korthuis, Young). The Rural Opioid Initiative studies that are integrated with PROUD-R2 are funded by UG3/UH3 DA044798 (PIs: Young, Cooper), UH3DA044831 (PI: Korthuis), UH3DA044822 (PI: Miller, Go). Kathy Lancaster was supported by K01DA048174 (PI: Lancaster). The project is also supported by UL1TR002369 (Oregon Clinical & Translational Research Institute), UL1TR001998 (University of Kentucky Center for Clinical and Translational Science), and UL1TR001070 (The Ohio State University Center for Clinical and Translational Science) from the National Institutes of Health and K12 HS026370 from AHRQ/PCORI. Funding PROUD-R2 is funded by the National Institutes of Health through NCATS U01TR002631 (MPIs: Korthuis, Young). The Rural Opioid Initiative studies that are integrated with PROUD-R2 are funded by UG3/UH3 DA044798 (PIs: Young, Cooper), UH3DA044831 (PI: Korthuis), UH3DA044822 (PI: Miller, Go). Kathy Lancaster was supported by K01DA048174 (PI: Lancaster). The project is also supported by UL1TR002369 (Oregon Clinical & Translational Research Institute), UL1TR001998 (University of Kentucky Center for Clinical and Translational Science), and UL1TR001070 (The Ohio State University Center for Clinical and Translational Science) from the National Institutes of Health and K12 HS026370 from AHRQ/ PCORI.

FinanciadoresNúmero del financiador
National Institutes of Health (NIH)
Agency for Healthcare Research and Quality
Patient-Centered Outcomes Research Institute
National Center for Advancing Translational Sciences (NCATS)K01DA048174, UL1TR002369, U01TR002631, UL1TR001998, UG3/UH3 DA044798, UH3DA044822, UL1TR001070, UH3DA044831
Ohio Water Resources Center, Ohio State UniversityK12 HS026370
Oregon Clinical and Translational Research Institute
University of Kentucky, Center for Clinical and Translational Science

    ODS de las Naciones Unidas

    Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

    1. Good health and well being
      Good health and well being

    ASJC Scopus subject areas

    • General Medicine

    Huella

    Profundice en los temas de investigación de 'Peer-based Retention of people who Use Drugs in Rural Research (PROUD-R 2): A multisite, randomised, 12-month trial to compare efficacy of standard versus peer-based approaches to retain rural people who use drugs in research'. En conjunto forman una huella única.

    Citar esto